This Apple-like Innovator is Revolutionizing Healthcare

AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.

Click here to learn more about the booming eHealth industry

PAA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 31.55%

Insider Buying (Last 12 Months): A$22,349.52

Insider Selling (Last 12 Months): A$0.00

PharmAust Insider Trading History Chart

PharmAust Share Price & Price History

A^$0.00

+0.30 (1.20%)

As of 05/13/2020 01:00 AM ET

Bitcoin Rockets To Record High But Buy THIS Instead

From Paradigm Press | Ad

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

PharmAust Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
2/23/2024	Sam Wright	Insider	Issued	450,000	A$0.10	A$45,000.00
12/15/2023	Roger Aston	Insider	Buy	3,649,904	A$0.01	A$18,249.52
10/31/2023	Neville Bassett	Insider	Expiry	1,750	A$0.07	A$122.50
7/7/2023	Sam Wright	Insider	Issued	250,000	A$0.08	A$20,000.00
5/10/2023	Sam Wright	Insider	Buy	50,000	A$0.08	A$4,100.00
3/10/2023	Sam Wright	Insider	Buy	85,000	A$0.09	A$7,395.00
1/9/2023	Sam Wright	Insider	Buy	165,000	A$0.07	A$11,550.00
9/13/2022	Sam Wright	Insider	Buy	250,000	A$0.08	A$18,750.00
11/9/2021	Roger Aston	Insider	Issued	3,649,904	A$0.01	A$36,499.04
8/24/2021	Sam Wright	Insider	Buy	500,000	A$0.09	A$42,500.00

top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)

From Traders Agency | Ad

AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.

Click here now for the full details of this stock that’s set to rocket in the AI revolution…

SEC Filings (Institutional Ownership Changes) for PharmAust (ASX:PAA)

PharmAust Limited develops targeted cancer therapeutics for humans and animals in Switzerland, Australia, Sweden, the United States, and internationally. The company develops drug discovery intellectual property for the treatment of various cancers, neurological diseases, and viral infections. Its lead candidate is Monepantel (MPL), a small molecule drug which is in Phase II clinical trials for the treatment of cancer. The company also provides products and services in synthetic and medicinal chemistry to the drug discovery and pharmaceutical industries worldwide. It serves drug discovery and pharmaceutical industries. PharmAust Limited was incorporated in 2000 and is based in Bentley, Australia.

Today's Range

Now: N/A

50 Day Range

MA: N/A

52 Week Range

Now: N/A

Volume

3,268,637 shs

Average Volume

N/A

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

3.88%

Beta

1.27

Who are the company insiders with the largest holdings of PharmAust?: PharmAust's top insider shareholders include:
Neville Bassett (Insider)
Roger Aston (Insider)
Sam Wright (Insider)
Learn More about top insider investors at PharmAust.